Australia markets open in 7 hours 19 minutes

Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6289+0.0089 (+1.44%)
At close: 04:00PM EDT
0.6076 -0.02 (-3.39%)
After hours: 07:22PM EDT

Insider transactions

Currency in USD
Insider purchases - Last 6 monthsSharesTrans
Purchases00
SalesN/A0
Net shares purchased (sold)00
Total insider shares held9.14MN/A
% net shares purchased (sold)N/AN/A
Net institutional purchases - Prior quarter to latest quarterShares
Net shares purchased (sold)N/A
% change in institutional shares heldN/A

Insider transactions reported - last two years

InsiderTransactionTypeValueDateShares

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct28 Mar 20249,956

ROBINSON CHANDLER D
Chief Executive Officer

Direct28 Mar 202424,474

CITTADINE ANDREW
Chief Operating Officer

Direct28 Mar 20248,952

STARR CHRISTOPHER M
Director

Direct29 Dec 20232,533

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct29 Dec 202311,188

ANDERSON RAYMOND WILLIAM
Director

Direct29 Dec 20232,533

KLAUSNER ARTHUR J
Director

Direct29 Dec 20232,533

BROWN MICHAEL J
Director

Direct29 Dec 20232,533

ROBINSON CHANDLER D
Chief Executive Officer

Direct29 Dec 202331,198

CITTADINE ANDREW
Chief Operating Officer

Direct29 Dec 20238,952

STARR CHRISTOPHER M
Director

Direct29 Sept 20232,533

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct29 Sept 20239,956

ANDERSON RAYMOND WILLIAM
Director

Direct29 Sept 20232,533

KLAUSNER ARTHUR J
Director

Direct29 Sept 20232,533

BROWN MICHAEL J
Director

Direct29 Sept 20232,533

ROBINSON CHANDLER D
Chief Executive Officer

Direct29 Sept 202324,474

CITTADINE ANDREW
Chief Operating Officer

Direct29 Sept 20238,953

STARR CHRISTOPHER M
Director

Direct30 June 20232,534

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct30 June 202314,846

ANDERSON RAYMOND WILLIAM
Director

Direct30 June 20232,534

KLAUSNER ARTHUR J
Director

Direct30 June 20232,534

BROWN MICHAEL J
Director

Direct30 June 20232,534

ROBINSON CHANDLER D
Chief Executive Officer

Direct30 June 202335,039

CITTADINE ANDREW
Chief Operating Officer

Direct30 June 202313,841

STARR CHRISTOPHER M
Director

Direct31 Mar 20232,533

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct31 Mar 20235,067

ANDERSON RAYMOND WILLIAM
Director

Direct31 Mar 20232,533

KLAUSNER ARTHUR J
Director

Direct31 Mar 20232,533

BROWN MICHAEL J
Director

Direct31 Mar 20232,533

ROBINSON CHANDLER D
Chief Executive Officer

Direct31 Mar 202313,911

CITTADINE ANDREW
Chief Operating Officer

Direct31 Mar 20234,063

STARR CHRISTOPHER M
Director

Direct30 Dec 20222,859

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct30 Dec 20226,297

ANDERSON RAYMOND WILLIAM
Director

Direct30 Dec 20222,859

KLAUSNER ARTHUR J
Director

Direct30 Dec 20222,859

BROWN MICHAEL J
Director

Direct30 Dec 20222,859

ROBINSON CHANDLER D
Chief Executive Officer

Direct30 Dec 202220,635

CITTADINE ANDREW
Chief Operating Officer

Direct30 Dec 20224,062

CITTADINE ANDREW
Chief Operating Officer

Purchase at price 3.00 - 3.15 per share.Direct49,65915 Nov 202216,053

STARR CHRISTOPHER M
Director

Direct30 Sept 20222,859

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct30 Sept 20225,066

ANDERSON RAYMOND WILLIAM
Director

Direct30 Sept 20222,859

KLAUSNER ARTHUR J
Director

Direct30 Sept 20222,859

BROWN MICHAEL J
Director

Direct30 Sept 20222,859

ROBINSON CHANDLER D
Chief Executive Officer

Direct30 Sept 202213,911

CITTADINE ANDREW
Chief Operating Officer

Direct30 Sept 20224,063

STARR CHRISTOPHER M
Director

Direct30 June 20222,859

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct30 June 20228,913

ANDERSON RAYMOND WILLIAM
Director

Direct30 June 20222,859

KLAUSNER ARTHUR J
Director

Direct30 June 20222,859

BROWN MICHAEL J
Director

Direct30 June 20222,859

ROBINSON CHANDLER D
Chief Executive Officer

Direct30 June 202223,882

CITTADINE ANDREW
Chief Operating Officer

Direct30 June 20228,125

STARR CHRISTOPHER M
Director

Direct31 Mar 20222,859

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct31 Mar 20221,221

ANDERSON RAYMOND WILLIAM
Director

Direct31 Mar 20222,859

KLAUSNER ARTHUR J
Director

Direct31 Mar 20222,859

BROWN MICHAEL J
Director

Direct31 Mar 20222,859

ROBINSON CHANDLER D
Chief Executive Officer

Direct31 Mar 20223,941

MAZAR ANDREW PAUL
Officer and Director

Direct31 Mar 20221,606

STARR CHRISTOPHER M
Director

Direct31 Dec 2021751

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct31 Dec 20211,221

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct31 Dec 20211,231

ANDERSON RAYMOND WILLIAM
Director

Direct31 Dec 2021751

KLAUSNER ARTHUR J
Director

Direct31 Dec 2021751

BROWN MICHAEL J
Director

Direct31 Dec 2021751

ROBINSON CHANDLER D
Chief Executive Officer

Direct31 Dec 20213,941

ROBINSON CHANDLER D
Chief Executive Officer

Direct31 Dec 20216,724

MAZAR ANDREW PAUL
Officer and Director

Direct31 Dec 20211,606

MAZAR ANDREW PAUL
Officer and Director

Direct31 Dec 20211,937

STARR CHRISTOPHER M
Director

Direct30 Sept 2021751

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct30 Sept 20211,221

ANDERSON RAYMOND WILLIAM
Director

Direct30 Sept 2021751

KLAUSNER ARTHUR J
Director

Direct30 Sept 2021751

BROWN MICHAEL J
Director

Direct30 Sept 2021751

ROBINSON CHANDLER D
Chief Executive Officer

Direct30 Sept 20213,941

MAZAR ANDREW PAUL
Officer and Director

Direct30 Sept 20211,606

STARR CHRISTOPHER M
Director

Direct30 June 2021752

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct30 June 20212,442

ANDERSON RAYMOND WILLIAM
Director

Direct30 June 2021752

KLAUSNER ARTHUR J
Director

Direct30 June 2021752

BROWN MICHAEL J
Director

Direct30 June 2021752

ROBINSON CHANDLER D
Chief Executive Officer

Direct30 June 20217,883

MAZAR ANDREW PAUL
Officer and Director

Direct30 June 20213,212

STARR CHRISTOPHER M
Director

Direct31 Mar 2021751

ANDERSON RAYMOND WILLIAM
Director

Direct31 Mar 2021751

KLAUSNER ARTHUR J
Director

Direct31 Mar 2021751

BROWN MICHAEL J
Director

Direct31 Mar 2021751

TACTIC PHARMA, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 10.60 per share.Indirect1,325,00011 Feb 2021125,000

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Direct01 Jan 20211,231

ROBINSON CHANDLER D
Chief Executive Officer

Direct01 Jan 20216,724

MAZAR ANDREW PAUL
Officer and Director

Direct01 Jan 20211,937

STARR CHRISTOPHER M
Director

Direct31 Dec 2020644

ANDERSON RAYMOND WILLIAM
Director

Direct31 Dec 2020644

KLAUSNER ARTHUR J
Director

Direct31 Dec 2020644

BROWN MICHAEL J
Director

Direct31 Dec 2020644

STARR CHRISTOPHER M
Director

Direct30 June 2020323

ANDERSON RAYMOND WILLIAM
Director

Direct30 June 2020323

KLAUSNER ARTHUR J
Director

Direct30 June 2020323

BROWN MICHAEL J
Director

Direct30 June 2020323

STARR CHRISTOPHER M
Director

Direct31 Mar 2020322

ANDERSON RAYMOND WILLIAM
Director

Direct31 Mar 2020322

KLAUSNER ARTHUR J
Director

Direct31 Mar 2020322

BROWN MICHAEL J
Director

Direct31 Mar 2020322

TSUCHIMOTO-EVANS KIM R
Chief Financial Officer

Purchase at price 8.00 per share.Direct2,60018 Dec 2019325

LEO KARL
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 8.00 per share.Indirect1,252,51018 Dec 2019156,564

HENDRICKS DIANE
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 8.00 per share.Indirect3,750,00018 Dec 2019468,750

TACTIC PHARMA, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 8.00 per share.Indirect1,000,00018 Dec 2019125,000

RIOUX PATRICE P
Officer

Conversion of Exercise of derivative security at price 0.00 - 6.00 per share.Direct109,99826 Nov 201918,433